A single lab result is a data point. A series of lab results over time is a story. The story — whether your ApoB is trending down, whether your HbA1c improved after starting time-restricted eating, whether your biological age is moving faster or slower than your chronological age — is what longevity medicine is actually about.
When you log when you started an intervention and track biomarkers before and after, you build personal evidence. Did your hsCRP improve after you started omega-3s? Did your fasting glucose drop after 3 months of time-restricted eating? Your body is the most relevant n=1 experiment you have access to — this dashboard helps you run it rigorously.
Many of the most dangerous biomarker trends are invisible in a single annual reading. Fasting insulin creeping from 6 to 9 to 12 uIU/mL over three years is clinically "normal" at every individual measurement — but represents a trajectory toward insulin resistance that's fully reversible if caught early. Trend data makes the invisible visible.
A printed or shared report card showing your biomarker trends, biological age estimate, and active protocols gives your physician context that a single lab result cannot. Longevity-focused care requires longitudinal data — this dashboard generates the summary that makes that conversation productive rather than starting from scratch at every visit.
The biological age estimate shown in this dashboard is a composite scoring model based on your logged biomarker values relative to longevity-optimal ranges. Each biomarker at its optimal level contributes positively; each biomarker outside the standard clinical range contributes negatively. The resulting score is mapped to a biological age delta relative to your chronological age.
This is a proxy model, not a clinical measurement. True biological age requires laboratory testing — epigenetic clocks like GrimAge (DNA methylation analysis), GlycanAge (IgG glycan profiling), or the Levine PhenoAge bloodwork panel. The dashboard estimate is directionally useful for tracking whether your interventions are moving your biomarker profile in the right direction, but carries ±3–5 year uncertainty.
The most important number in this dashboard is not your biological age estimate on any given day — it is the direction of the trend line over 12–24 months of consistent tracking. A biological age trending from 52 toward 48 over two years, correlated with a specific set of protocol changes, is meaningful evidence that your interventions are working.